Charles Schwab
NXGN

Charles Schwab’s NextGen Healthcare, Inc. Common Stock NXGN Stock Holding History

Charles Schwab’s Portfolio NXGN Stock Details NXGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-630,387
Closed -$15M – 3592
2023
Q3 		$15M Sell
630,387
-115,373
-15% -$2.17M ﹤0.01% 1682
2023
Q2 		$12.1M Buy
745,760
+40,356
+6% +$669K ﹤0.01% 1824
2023
Q1 		$12.3M Buy
705,404
+22,038
+3% +$396K ﹤0.01% 1775
2022
Q4 		$12.8M Buy
683,366
+51,700
+8% +$996K ﹤0.01% 1714
2022
Q3 		$11.2M Sell
631,666
-37,870
-6% -$657K ﹤0.01% 1777
2022
Q2 		$11.7M Sell
669,536
-5,576
-0.8% -$106K ﹤0.01% 1753
2022
Q1 		$14.1M Sell
675,112
-4,277
-0.6% -$81.9K ﹤0.01% 1759
2021
Q4 		$12.1M Buy
679,389
+8,885
+1% +$143K ﹤0.01% 1904
2021
Q3 		$9.46M Buy
670,504
+10,867
+2% +$169K ﹤0.01% 2045
2021
Q2 		$10.9M Buy
659,637
+119,805
+22% +$2.15M ﹤0.01% 1948
2021
Q1 		$9.77M Buy
539,832
+10,090
+2% +$199K ﹤0.01% 1977
2020
Q4 		$9.66M Buy
529,742
+17,307
+3% +$275K ﹤0.01% 1887
2020
Q3 		$6.53M Buy
512,435
+13,317
+3% +$170K ﹤0.01% 1940
2020
Q2 		$5.48M Buy
499,118
+2,283
+0.5% +$23.7K ﹤0.01% 1981
2020
Q1 		$5.19M Buy
496,835
+12,344
+3% +$159K ﹤0.01% 1813
2019
Q4 		$7.79M Sell
484,491
-32,716
-6% -$541K ﹤0.01% 1791
2019
Q3 		$8.11M Buy
517,207
+32,064
+7% +$533K ﹤0.01% 1722
2019
Q2 		$9.65M Buy
485,143
+5,996
+1% +$112K 0.01% 1609
2019
Q1 		$8.06M Sell
479,147
-7,049
-1% -$122K 0.01% 1723
2018
Q4 		$7.37M Sell
486,196
-43,867
-8% -$753K 0.01% 1661
2018
Q3 		$10.6M Sell
530,063
-50,181
-9% -$1.06M 0.01% 1596
2018
Q2 		$11.3M Sell
580,244
-236,555
-29% -$3.74M 0.01% 1508
2018
Q1 		$11.2M Sell
816,799
-167,603
-17% -$2.21M 0.01% 1416
2017
Q4 		$13.4M Sell
984,402
-9,844
-1% -$141K 0.01% 1286
2017
Q3 		$15.6M Buy
994,246
+16,452
+2% +$266K 0.01% 1106
2017
Q2 		$16.8M Buy
977,794
+265,798
+37% +$4.04M 0.02% 983
2017
Q1 		$10.9M Buy
711,996
+325,957
+84% +$4.8M 0.01% 1264
2016
Q4 		$5.08M Sell
386,039
-6,224
-2% -$79.7K 0.01% 1733
2016
Q3 		$4.44M Buy
392,263
+13,000
+3% +$156K 0.01% 1728
2016
Q2 		$4.52M Buy
379,263
+13,789
+4% +$185K 0.01% 1624
2016
Q1 		$5.57M Buy
365,474
+10,384
+3% +$157K 0.01% 1452
2015
Q4 		$5.72M Sell
355,090
-221,390
-38% -$3.23M 0.01% 1425
2015
Q3 		$7.2M Buy
576,480
+27,216
+5% +$374K 0.01% 1202
2015
Q2 		$9.1M Buy
549,264
+8,427
+2% +$136K 0.01% 1118
2015
Q1 		$8.64M Buy
540,837
+59,856
+12% +$990K 0.01% 1102
2014
Q4 		$7.5M Buy
480,981
+46,990
+11% +$687K 0.01% 1107
2014
Q3 		$5.98M Buy
433,991
+124,546
+40% +$1.89M 0.01% 1214
2014
Q2 		$4.97M Buy
309,445
+196,890
+175% +$3.11M 0.01% 1401
2014
Q1 		$1.9M Buy
112,555
+3,136
+3% +$56.9K ﹤0.01% 1984
2013
Q4 		$2.31M Buy
109,419
+4,052
+4% +$91.3K ﹤0.01% 1829
2013
Q3 		$2.34M Buy
105,367
+14,407
+16% +$307K ﹤0.01% 1749
2013
Q2 		$1.78M Buy
+90,960
New +$1.66M ﹤0.01% 1834

Other funds holding NXGN

HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Charles Schwab's NXGN Position: Q4 2023 in Review

Charles Schwab sold out of NextGen Healthcare, Inc. Common Stock (NXGN) in Q4 2023, closing a stake of 630,387 shares — an estimated $15M sold.

Charles Schwab first reported a position in NXGN in Q2 2013 and held it in 42 quarters. The position peaked at $16.8M in Q2 2017. 1 fund tracked by Wall St. Rank holds NXGN as of Q4 2023.

  • Charles Schwab reported no remaining NextGen Healthcare, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Charles Schwab sold 630,387 NextGen Healthcare, Inc. Common Stock shares in Q4 2023, an estimated $15M.
  • Charles Schwab first reported a position in NextGen Healthcare, Inc. Common Stock in Q2 2013 and held it in 42 quarters.
  • Charles Schwab's NextGen Healthcare, Inc. Common Stock position peaked at $16.8M in Q2 2017.
  • 1 fund tracked by Wall St. Rank held NextGen Healthcare, Inc. Common Stock as of Q4 2023.

Based on Charles Schwab's 13F filing for Q4 2023, filed 6 Feb 2024.